LONDON (Alliance News) - AstraZeneca PLC said Thursday that it had initiated its Phase III immunotherapy study for the compound MEDI4736 for the treatment of non-small cell lung cancer. The study will assess progression-free survival and the overall survival rate of patients treated with th Read More
LONDON (Alliance News) - US drugs giant Pfizer IncWednesday further detailed its case for combining its business with AstraZeneca PLC, after the UK drugsmaker Tuesday called for shareholders to be patient as it set out growth plans for the coming three years. Pfizer said Wednesday that with Read More
LONDON (Alliance News) - The FTSE 100 lost ground Tuesday, snapping a five day winning streak as investors returned from a long weekend, over which the conflict in Ukraine continued to escalate, to some disappointing corporate news from the likes of <strong>Barclays</strong> and <strong>Balfou Read More
LONDON (Alliance News) - <strong>AstraZeneca</strong> Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly after it invests in its pipeline and transforms the company over the next few Read More
LONDON (Alliance News) - British drugs company AstraZeneca PLC Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly once it has invested in its pipeline and transformed the company over th Read More
LONDON (Alliance News) - British drugs company AstraZeneca PLC Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly after it invests in its piepline and transforms the company over the nex Read More
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />British drugs company<strong> AstraZeneca</strong> PLC set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urgi Read More
(Correcting AstraZeneca made its statement on Tuesday.) LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Persimmon</strong>, up 3 Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Persimmon</strong>, up 3.6%, and <strong>Barratt Developments</strong>, up 1.8%. The h Read More
LONDON (Alliance News) - UK shares have opened marginally higher Tuesday despite growing tensions in Ukraine but following a modestly positive lead from Wall Street on Monday.<br /><br />Several major UK companies have provided quarterly updates early Tuesday.<br /><br /><strong>Barclays</stro Read More
LONDON (Alliance News) - AstraZeneca PLC, which has rejected a GBP63 billion takeover offer from US rival Pfizer Inc, Tuesday said the US Food and Drug Administration had approved its Epanova drug as a treatment for reducing high levels of blood fat. In a statement, the company said the FDA Read More
LONDON (Alliance News) - AstraZeneca PLC, which rejected Pfizer Inc?s informal GBP50-per-share proposal last week as a ?substantial? undervaluation, will on Tuesday issue details of its strengthening pipeline of new drugs, including some promising cancer therapies, in an effort to persuade invest Read More
LONDON (Alliance News) - The FTSE 100 ended modestly higher Friday ahead of a holiday weekend, having closed in positive territory every day this week. Throughout the week, the blue-chip index has been boosted by strong performances in turn by some of its key individual constituents, and Fr Read More
LONDON (Alliance News) - <strong>InterContinental Hotels</strong> Group saw its share price jump Friday after the company declared a USD750 million special dividend and reported strong results for its first quarter. <br /><br />IHG's dividend comes after the firm completed two asset disposals Read More
LONDON (Alliance News) - US stocks are set to follow UK indices marginally higher Friday, with investors treading carefully ahead of the monthly US non-farm payroll report, due at 1230 GMT. Futures trading suggests that the DJIA, the S&P 500, and the Nasdaq Composite all will open between f Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />---------<br /><strong>AstraZeneca</strong> PLC rejected Pfizer Inc's second bid for the company, saying that despite Pfizer raising its bid to GBP50 per share i Read More
LONDON (Alliance News) - AstraZeneca PLC Friday rejected Pfizer Inc's second bid for the company, saying that despite Pfizer raising its bid to GBP50 per share it still "significantly undervalue[s]" the company and that the details of the proposal are "inadequate." AstraZeneca advised share Read More
LONDON (Alliance News) - UK stocks are trading marginally higher Friday, with a strong update from Royal Bank of Scotland and continued merger talk in the pharmaceutical sector trumping concerns over a deteriorating situation in Ukraine. Markets as a whole remain relatively subdued ahead of Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 3775 (3570) PENCE - 'HOLD' <br />----------<br />BERNSTEIN RAISES ASTRAZENECA PRICE Read More
LONDON (Alliance News) - UK shares have opened flat to slightly higher Friday, as pharmaceuticals and banks continue at the forefront.<br /><br />Pfizer confirmed that it has made an increased offer for <strong>AstraZeneca</strong> PLC of GBP50 per share, in cash and Pfizer shares. Pfize Read More